Trials / Completed
CompletedNCT00997633
Single-photon Emission Computed Tomography (SPECT) to Predict Peritoneal Chemotherapy
Single-photon Emission Computed Tomography for Prediction of Treatment Results in Sequential Intraperitoneal Chemotherapy at Peritoneal Carcinomatosis
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 51 (actual)
- Sponsor
- Uppsala University · Academic / Other
- Sex
- All
- Age
- 14 Years – 74 Years
- Healthy volunteers
- Not accepted
Summary
SPECT was performed in 51 patients after cytoreductive surgery in combination with intraperitoneal chemotherapy. The detected volume was compared to the number of subsequent sequential postoperative intraperitoneal chemotherapy courses that could be performed without further surgical intervention. SPECT data was found to predict feasibility of sequential postoperative intraperitoneal chemotherapy.
Conditions
Timeline
- Start date
- 1991-05-01
- Primary completion
- 2004-08-01
- Completion
- 2004-08-01
- First posted
- 2009-10-19
- Last updated
- 2009-10-19
Locations
1 site across 1 country: Sweden
Source: ClinicalTrials.gov record NCT00997633. Inclusion in this directory is not an endorsement.